Search Results
Displaying 251 - 260 of 1057
… On this page What is a Phased Award? Phased awards provide research support in … from the email address NINDS_submissions@ninds.nih.gov . It can take a significant amount of time to prepare a Type 4 …
… system, especially in the context of movement disorders. Efforts were directed toward identifying … compensate for dysfunction occurring in these systems in disorders such as Parkinson's disease, dyskinesia, … Tourette's syndrome and attention deficit/hyperactivity disorder (ADHD). Neurophysiological approaches were utilized …
… clinical fellow in a combined program focused on movement disorder neurology and basic neuroscience research. Before …
… Program Director Image Division of Neuroscience Movement Disorders and Neurodegeneration Synucleinopathies, including … Dr. Beth-Anne Sieber is a program director in the Movement Disorders and Neurodegeneration (MDN) cluster, managing … grant portfolio on Parkinson’s disease (PD) and related disorders, dystonia and essential tremor. Her PD grant …
… The goal of the R35 (R35; RPA; RFA-NS-22-038 ) is to help investigators make meaningful contributions to … greater funding stability, flexibility, and support for your overall research project. Use this page to learn more … the work and to de-emphasize details of the approach. Q. How can I decide if RPA is right for my circumstances? Assess …
… Path (C-Path) for Rare Neurodegenerative Diseases (CP-RND) Accelerating Medicines Partnership® for Amyotrophic … Path (C-Path) for Rare Neurodegenerative Diseases (CP-RND) is a public-private collaboration focused on …
… September 13, 2019 By Dr. Walter Koroshetz, NINDS Director and Dr. Nina Schor, NINDS Deputy Director For this Director’s … released Request for Information . I invite you to provide your input at this early stage, which will be invaluable for … have repeatedly exceeded my expectations. That is why I am so excited to ask them to take a step out of the …
… Neurodegeneration, Dementia, and Repeat Expansion Disorders Contact elio.peraza@nih.gov Elio Peraza is the ALS …
… Parkinson’s disease (PD) is a chronic, progressive movement disorder that … of the disease. To inform ongoing and future efforts in PD research, the National Institute of Neurological Disorders …
… is considerable concern, but much uncertainty, about long-term neurological disability. The multiplicity of … sensitivity to disruption present formidable challenges to medical science. Despite these obstacles, since Congress … funded through the NIH Office of the Director, develops medical countermeasures for toxic exposures after a chemical …